vs
柯达（KODK）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
柯达的季度营收约是REPLIGEN CORP的1.5倍（$290.0M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -37.2%，领先44.0%），REPLIGEN CORP同比增速更快（13.6% vs 9.0%），柯达自由现金流更多（$483.0M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.9%）
伊士曼柯达公司，常简称为柯达，是一家源自美国的知名影像企业，总部位于纽约州罗切斯特，注册于新泽西州。柯达在摄影胶片领域拥有悠久的历史，曾率先将摄影胶片产品推向大众市场，如今仍围绕传统胶片影像业务开发各类相关产品。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
KODK vs RGEN — 直观对比
营收规模更大
KODK
是对方的1.5倍
$197.9M
营收增速更快
RGEN
高出4.6%
9.0%
净利率更高
RGEN
高出44.0%
-37.2%
自由现金流更多
KODK
多$465.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $290.0M | $197.9M |
| 净利润 | $-108.0M | $13.3M |
| 毛利率 | 23.1% | 52.5% |
| 营业利润率 | -0.3% | 9.0% |
| 净利率 | -37.2% | 6.7% |
| 营收同比 | 9.0% | 13.6% |
| 净利润同比 | -515.4% | 143.9% |
| 每股收益（稀释后） | $-1.22 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KODKRGEN
| Q4 25 | $290.0M | $197.9M | ||
| Q3 25 | $269.0M | $188.8M | ||
| Q2 25 | $263.0M | $182.4M | ||
| Q1 25 | $247.0M | $169.2M | ||
| Q4 24 | $266.0M | $174.1M | ||
| Q3 24 | $261.0M | $154.9M | ||
| Q2 24 | $267.0M | $154.1M | ||
| Q1 24 | $249.0M | $151.3M |
净利润KODKRGEN
| Q4 25 | $-108.0M | $13.3M | ||
| Q3 25 | $13.0M | $14.9M | ||
| Q2 25 | $-26.0M | $14.9M | ||
| Q1 25 | $-7.0M | $5.8M | ||
| Q4 24 | $26.0M | $-30.3M | ||
| Q3 24 | $18.0M | $-654.0K | ||
| Q2 24 | $26.0M | $3.3M | ||
| Q1 24 | $32.0M | $2.1M |
毛利率KODKRGEN
| Q4 25 | 23.1% | 52.5% | ||
| Q3 25 | 25.3% | 53.2% | ||
| Q2 25 | 19.4% | 50.0% | ||
| Q1 25 | 18.6% | 53.6% | ||
| Q4 24 | 19.2% | 26.1% | ||
| Q3 24 | 17.2% | 50.0% | ||
| Q2 24 | 21.7% | 49.8% | ||
| Q1 24 | 19.7% | 49.5% |
营业利润率KODKRGEN
| Q4 25 | -0.3% | 9.0% | ||
| Q3 25 | 7.1% | 8.9% | ||
| Q2 25 | -1.9% | 7.6% | ||
| Q1 25 | -5.3% | 3.9% | ||
| Q4 24 | -3.0% | -17.7% | ||
| Q3 24 | -3.1% | -5.1% | ||
| Q2 24 | 0.7% | 1.0% | ||
| Q1 24 | 2.8% | 1.3% |
净利率KODKRGEN
| Q4 25 | -37.2% | 6.7% | ||
| Q3 25 | 4.8% | 7.9% | ||
| Q2 25 | -9.9% | 8.2% | ||
| Q1 25 | -2.8% | 3.4% | ||
| Q4 24 | 9.8% | -17.4% | ||
| Q3 24 | 6.9% | -0.4% | ||
| Q2 24 | 9.7% | 2.2% | ||
| Q1 24 | 12.9% | 1.4% |
每股收益（稀释后）KODKRGEN
| Q4 25 | $-1.22 | $0.24 | ||
| Q3 25 | $-0.08 | $0.26 | ||
| Q2 25 | $-0.36 | $0.26 | ||
| Q1 25 | $-0.12 | $0.10 | ||
| Q4 24 | $0.22 | $-0.55 | ||
| Q3 24 | $0.15 | $-0.01 | ||
| Q2 24 | $0.23 | $0.06 | ||
| Q1 24 | $0.30 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $436.0M | $767.6M |
| 总债务越低越好 | $209.0M | $542.2M |
| 股东权益账面价值 | $614.0M | $2.1B |
| 总资产 | $1.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资KODKRGEN
| Q4 25 | $436.0M | $767.6M | ||
| Q3 25 | $168.0M | $748.7M | ||
| Q2 25 | $155.0M | $708.9M | ||
| Q1 25 | $158.0M | $697.2M | ||
| Q4 24 | $201.0M | $757.4M | ||
| Q3 24 | $214.0M | $784.0M | ||
| Q2 24 | $251.0M | $809.1M | ||
| Q1 24 | $262.0M | $780.6M |
总债务KODKRGEN
| Q4 25 | $209.0M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $467.0M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KODKRGEN
| Q4 25 | $614.0M | $2.1B | ||
| Q3 25 | $762.0M | $2.1B | ||
| Q2 25 | $528.0M | $2.1B | ||
| Q1 25 | $563.0M | $2.0B | ||
| Q4 24 | $641.0M | $2.0B | ||
| Q3 24 | $982.0M | $2.0B | ||
| Q2 24 | $961.0M | $2.0B | ||
| Q1 24 | $951.0M | $2.0B |
总资产KODKRGEN
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $2.1B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $2.0B | $2.8B | ||
| Q3 24 | $2.4B | $2.8B | ||
| Q2 24 | $2.4B | $2.9B | ||
| Q1 24 | $2.3B | $2.8B |
负债/权益比KODKRGEN
| Q4 25 | 0.34× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.73× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $489.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $483.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 166.6% | 8.9% |
| 资本支出强度资本支出/营收 | 2.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $446.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流KODKRGEN
| Q4 25 | $489.0M | $25.7M | ||
| Q3 25 | $21.0M | $48.1M | ||
| Q2 25 | $8.0M | $28.6M | ||
| Q1 25 | $-38.0M | $15.0M | ||
| Q4 24 | $4.0M | $39.2M | ||
| Q3 24 | $-21.0M | $49.3M | ||
| Q2 24 | $-7.0M | $42.2M | ||
| Q1 24 | $17.0M | $44.7M |
自由现金流KODKRGEN
| Q4 25 | $483.0M | $17.6M | ||
| Q3 25 | $17.0M | $43.4M | ||
| Q2 25 | $-4.0M | $21.5M | ||
| Q1 25 | $-50.0M | $11.4M | ||
| Q4 24 | $-13.0M | $33.6M | ||
| Q3 24 | $-41.0M | $42.3M | ||
| Q2 24 | $-16.0M | $37.4M | ||
| Q1 24 | $7.0M | $36.4M |
自由现金流率KODKRGEN
| Q4 25 | 166.6% | 8.9% | ||
| Q3 25 | 6.3% | 23.0% | ||
| Q2 25 | -1.5% | 11.8% | ||
| Q1 25 | -20.2% | 6.8% | ||
| Q4 24 | -4.9% | 19.3% | ||
| Q3 24 | -15.7% | 27.3% | ||
| Q2 24 | -6.0% | 24.3% | ||
| Q1 24 | 2.8% | 24.0% |
资本支出强度KODKRGEN
| Q4 25 | 2.1% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 4.6% | 3.9% | ||
| Q1 25 | 4.9% | 2.1% | ||
| Q4 24 | 6.4% | 3.2% | ||
| Q3 24 | 7.7% | 4.5% | ||
| Q2 24 | 3.4% | 3.1% | ||
| Q1 24 | 4.0% | 5.5% |
现金转化率KODKRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.62× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | -1.17× | — | ||
| Q2 24 | -0.27× | 12.70× | ||
| Q1 24 | 0.53× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KODK
| Segment Continuing Operations | $195.0M | 67% |
| Advanced Materials And Chemicals | $85.0M | 29% |
| Other | $7.0M | 2% |
| All Other | $3.0M | 1% |
RGEN
暂无分部数据
